Answers are grounded in this paper and cite their sources.
Adverse outcome pathways (AOPs) are pragmatic descriptions of how molecular perturbations can lead to adverse effects in intact organisms. To examine connectivity across endocrine signalling pathways, we integrated 117 AOPs related to oestrogen, androgen, steroidogenesis, thyroid and retinoic acid (EATS,R) modalities into a unified endocrine AOP network (AOPN). The resulting network revealed uneven pathway representation, limited mechanistic integration across EATS,R modalities and substantial gaps in certain signalling coverage, with only six retinoic acid-related AOPs available for integration. At the same time, the AOPN identified highly connected biological nodes linking multiple pathways to adverse outcomes, highlighting potential points of endocrine crosstalk as well as cross-species key events (KEs), bridging human and environmental health. To strengthen retinoid pathway integration, new KEs describing altered retinoic acid receptor activation were developed as potential network hubs (KE 2419 and KE 2420). Collectively, these findings demonstrate how the AOPN reveals emergent biological relationships, exposes knowledge gaps and identifies candidate targets for NAM development, providing a framework that could be used to prioritise future AOP development, and overall, to support a more integrated, system-level approach to endocrine disruptor identification.
No takes yet. Share an insight, caveat, or question.
Giorgi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: